PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.49%
Negative revenue growth while UPM.HE stands at 33.49%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.01%
Negative gross profit growth while UPM.HE is at 109.68%. Joel Greenblatt would examine cost competitiveness or demand decline.
-11.66%
Negative EBIT growth while UPM.HE is at 133.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.66%
Negative operating income growth while UPM.HE is at 133.13%. Joel Greenblatt would press for urgent turnaround measures.
10.43%
Net income growth under 50% of UPM.HE's 115.90%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.00%
EPS growth under 50% of UPM.HE's 116.98%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.00%
Diluted EPS growth under 50% of UPM.HE's 116.98%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.24%
Share change of 0.24% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.39%
Diluted share change of 0.39% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
2359.26%
OCF growth above 1.5x UPM.HE's 77.13%. David Dodd would confirm a clear edge in underlying cash generation.
125.27%
FCF growth above 1.5x UPM.HE's 55.24%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-14.44%
Negative 10Y revenue/share CAGR while UPM.HE stands at 30.74%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
35.92%
5Y revenue/share CAGR similar to UPM.HE's 37.19%. Walter Schloss might see both companies benefiting from the same mid-term trends.
32.32%
3Y revenue/share CAGR at 75-90% of UPM.HE's 37.18%. Bill Ackman would expect new product strategies to close the gap.
37.33%
Positive long-term OCF/share growth while UPM.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-1.14%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
51.60%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
932.84%
Net income/share CAGR at 50-75% of UPM.HE's 1724.67%. Martin Whitman might question if the firm’s product or cost base lags behind.
200.46%
5Y net income/share CAGR above 1.5x UPM.HE's 113.64%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
261.54%
3Y net income/share CAGR above 1.5x UPM.HE's 147.37%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
68.01%
10Y equity/share CAGR 1.25-1.5x UPM.HE's 58.03%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
77.29%
5Y equity/share CAGR above 1.5x UPM.HE's 43.16%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
51.46%
3Y equity/share CAGR above 1.5x UPM.HE's 22.28%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.48%
Inventory growth well above UPM.HE's 18.92%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
10.59%
Asset growth at 50-75% of UPM.HE's 14.82%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
11.92%
1.25-1.5x UPM.HE's 8.86%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
0.61%
Debt shrinking faster vs. UPM.HE's 32.61%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-27.51%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.